ES550089A0 - Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. - Google Patents

Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Info

Publication number
ES550089A0
ES550089A0 ES550089A ES550089A ES550089A0 ES 550089 A0 ES550089 A0 ES 550089A0 ES 550089 A ES550089 A ES 550089A ES 550089 A ES550089 A ES 550089A ES 550089 A0 ES550089 A0 ES 550089A0
Authority
ES
Spain
Prior art keywords
coadjuvated
viruses
bacteria
proteins
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES550089A
Other languages
English (en)
Other versions
ES8801583A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES8801583A1 publication Critical patent/ES8801583A1/es
Publication of ES550089A0 publication Critical patent/ES550089A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES550089A 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. Expired ES8801583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843446515 DE3446515A1 (de) 1984-12-20 1984-12-20 Oeladjuvierte vaccine und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8801583A1 ES8801583A1 (es) 1988-02-16
ES550089A0 true ES550089A0 (es) 1988-02-16

Family

ID=6253325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550089A Expired ES8801583A1 (es) 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Country Status (8)

Country Link
EP (1) EP0187286A1 (es)
DE (1) DE3446515A1 (es)
DK (1) DK593985A (es)
ES (1) ES8801583A1 (es)
FI (1) FI855057A (es)
GR (1) GR853058B (es)
NO (1) NO855169L (es)
PT (1) PT81713B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DE3817531A1 (de) * 1988-05-24 1989-12-07 Behringwerke Ag Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL269002A (es) * 1960-09-06
GB1083815A (en) * 1963-10-01 1967-09-20 Wellcome Found Vaccine adjuvants
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
DE3261734D1 (en) * 1981-03-03 1985-02-14 Centraal Diergeneeskundig Inst Water-in-oil emulsion for use in the potentation of the immune system of animals
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen

Also Published As

Publication number Publication date
GR853058B (es) 1986-04-15
PT81713A (de) 1986-01-01
DE3446515A1 (de) 1986-06-26
EP0187286A1 (de) 1986-07-16
ES8801583A1 (es) 1988-02-16
DK593985A (da) 1986-06-21
DK593985D0 (da) 1985-12-19
FI855057A0 (fi) 1985-12-18
FI855057A (fi) 1986-06-21
NO855169L (no) 1986-06-23
PT81713B (de) 1987-08-10

Similar Documents

Publication Publication Date Title
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
DE3882144D1 (de) Gefluegelpocken-virus-promotoren.
ZA853026B (en) Leukemia-associated virus immunogen,vaccine and assay
ES552169A0 (es) Un metodo para tratar termicamente, inactivando virus, a una solucion acuosa de gamma-globulina
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
DE3268361D1 (en) New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process
ES521411A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus.
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
ES553757A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
ES529225A0 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
ATE16454T1 (de) Influenzavirus-vaccine, verfahren zu ihrer herstellung und verfahren zur vermehrung von influenzaviren.
DE3650319D1 (de) Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).
ES527588A0 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
ES500199A0 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
NZ213249A (en) Protein antigen, dna, plasmid, transformed microorganism and influenza vaccine
DE3689144D1 (de) Pseudorabiesvirus-Protein.
ES487062A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
DK41885D0 (da) 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
EP0198828A4 (en) VACCINE AGAINST THE VIRUSES OF INFECTIOUS BURSAL DISEASE.
ES548889A0 (es) Un procedimiento para preparar una vacuna anti-helmintica que comprende una suspension, homogeneizado o extracto de una especie de nematodo y un vehiculo farmaceutico.
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.